LONDON, April 1, 2014 /PRNewswire/ --
On Monday, March 31, 2014, the US
markets saw a positive sentiment, as the NASDAQ Composite closed at
4,198.99, up 1.04%, the Dow Jones Industrial Average ended the
session at 16,457.66, up 0.82% and the S&P 500 edged 0.79%
higher to finish the trading session at 1,872.34. The gains were
broad based as nine out of 10 sectors ended the session in
positive. A number of stocks saw large movements, including Sangamo
BioSciences Inc. (NASDAQ: SGMO), Synthesis Energy Systems Inc.
(NASDAQ: SYMX), OXiGENE Inc. (NASDAQ: OXGN) and Affymetrix Inc.
(NASDAQ: AFFX). Free technical research on SGMO, SYMX, OXGN and
AFFX can be downloaded upon signing up at:
http://www.investor-edge.com/637-register
Shares in Sangamo BioSciences Inc. edged 8.00% higher, finishing
Monday's session at $18.08. The stock
fluctuated between $16.76 and $18.16
during the session with a trading volume of 2.32 million shares as
compared to a three months average volume of 1.59 million shares.
Shares in Sangamo BioSciences Inc. have advanced 30.17% in the
previous three months and on YTD basis, while the same has fallen
by 0.66% in the last one month. The S&P 500 Health Care Sector
Index mapped a gain of 1.27% during the trading session, while the
same has lost 1.37% in the last one month. Furthermore, the stock
has a Relative Strength Index (RSI) of 31.34 and is trading above
its 200-day moving average of $13.11.
Sign up today to read free research on SGMO at:
http://www.investor-edge.com/637-SGMO-01Apr2014.pdf
On Monday, shares in Synthesis Energy Systems Inc. ended the
session up 10.11% at an intra-day high of $1.96. A total of 1.17 million shares were traded
as compared to a three months average volume of 1.06 million
shares. During the session, the stock traded between $1.76 and $1.96.
Shares in Synthesis Energy Systems Inc. have rallied 18.79% in the
last one month and 226.67% on YTD basis. The S&P 500 Energy
Sector Index mapped a loss of 0.01% during the trading session,
while the same has advanced 2.28% in the last one month. Further,
the stock has an RSI of 53.65 and is trading above its 50-day and
200-day moving averages of $1.50 and
$0.95, respectively. Sign up today to
read free research on SYMX at:
http://www.investor-edge.com/637-SYMX-01Apr2014.pdf
OXiGENE Inc.'s stock finished Monday's session at $3.73, up 4.34%. A total of 0.84 million shares
were traded which is below the three months average volume of 1.60
million shares. The stock vacillated between $3.55 and $3.83 during the session. Shares in
OXiGENE Inc. have surged 75.94% in the last one month and 48.02% on
YTD basis. The S&P 500 Health Care Sector Index mapped a gain
of 1.27% during the trading session and has charted up 5.40% in the
previous three months. Additionally, the stock has an RSI of 58.72
and is trading above its 50-day and 200-day moving averages of
$2.75 and $2.68, respectively. Sign up today to read free
research on OXGN at:
http://www.investor-edge.com/637-OXGN-01Apr2014.pdf
Affymetrix Inc.'s stock closed Monday's session at $7.13, which is 7.22% higher than the previous
day's closing price of $6.65. A total
of 1.22 million shares were traded as compared to a three months
average volume of 1.40 million shares. The stock oscillated between
$6.71 and $7.15 during the trading
session. Affymetrix Inc.'s shares have gained 5.94% in the previous
three trading sessions, while the same has declined 7.64% in the
last one month and 16.80% on YTD basis. The S&P 500 Health Care
Sector Index mapped a gain of 1.27% during the trading session,
while the same has lost 1.37% in the last one month. Moreover, the
stock has an RSI of 34.94 and is trading above its 200-day moving
average of $6.76. Sign up today to
read free research on AFFX at:
http://www.investor-edge.com/637-AFFX-01Apr2014.pdf
===============
EDITOR'S NOTES:
===============
1. This is not company news. We are an independent source and
our views do not reflect the companies mentioned.
2. Information in this release is fact checked and produced on a
best efforts basis and reviewed by Nidhi Vatsal, a CFA
charterholder. However, we are only human and are prone to make
mistakes. If you notice any errors or omissions, please notify us
below.
3. This information is submitted as a net-positive to companies
mentioned, to increase awareness for mentioned companies to our
subscriber base and the investing public.
4. If you wish to have your company covered in more detail by
our team, or wish to learn more about our services, please contact
us at pubco [at] http://www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at
compliance [at] http://www.investor-edge.com.
6. Are you a public company? Would you like to see similar
coverage on your company? Send us a full investors' package to
research [at] http://www.investor-edge.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis.
This document, article or report is prepared and authored by
Investor-edge. An outsourced research services provider represented
by Nidhi Vatsal, CFA, has only reviewed the information provided by
Investor-edge in this article or report according to the Procedures
outlined by Investor-edge. Investor-edge is not entitled to veto or
interfere in the application of such procedures by the outsourced
provider to the articles, documents or reports, as the case may
be.
NOT FINANCIAL ADVICE
Investor-edge makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or
otherwise), of the information provided in this document. This
information is not to be construed as personal financial advice.
Readers are encouraged to consult their personal financial advisor
before making any decisions to buy, sell or hold any securities
mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-edge is not responsible for any error which may be
occasioned at the time of printing of this document or any error,
mistake or shortcoming. No liability is accepted by Investor-edge
whatsoever for any direct, indirect or consequential loss arising
from the use of this document. Investor-edge expressly disclaims
any fiduciary responsibility or liability for any consequences,
financial or otherwise arising from any reliance placed on the
information in this document. Investor-edge does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or(2) warrant any results from use of the information.
The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
http://www.investor-edge.com/
SOURCE Investor-Edge